Correlation Between Jindal Poly and Krebs Biochemicals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jindal Poly and Krebs Biochemicals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jindal Poly and Krebs Biochemicals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jindal Poly Investment and Krebs Biochemicals and, you can compare the effects of market volatilities on Jindal Poly and Krebs Biochemicals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jindal Poly with a short position of Krebs Biochemicals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jindal Poly and Krebs Biochemicals.

Diversification Opportunities for Jindal Poly and Krebs Biochemicals

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Jindal and Krebs is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Jindal Poly Investment and Krebs Biochemicals and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krebs Biochemicals and and Jindal Poly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jindal Poly Investment are associated (or correlated) with Krebs Biochemicals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krebs Biochemicals and has no effect on the direction of Jindal Poly i.e., Jindal Poly and Krebs Biochemicals go up and down completely randomly.

Pair Corralation between Jindal Poly and Krebs Biochemicals

Assuming the 90 days trading horizon Jindal Poly Investment is expected to under-perform the Krebs Biochemicals. But the stock apears to be less risky and, when comparing its historical volatility, Jindal Poly Investment is 1.31 times less risky than Krebs Biochemicals. The stock trades about -0.32 of its potential returns per unit of risk. The Krebs Biochemicals and is currently generating about -0.24 of returns per unit of risk over similar time horizon. If you would invest  11,120  in Krebs Biochemicals and on October 12, 2024 and sell it today you would lose (1,595) from holding Krebs Biochemicals and or give up 14.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Jindal Poly Investment  vs.  Krebs Biochemicals and

 Performance 
       Timeline  
Jindal Poly Investment 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Jindal Poly Investment are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Jindal Poly is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.
Krebs Biochemicals and 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Jindal Poly and Krebs Biochemicals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jindal Poly and Krebs Biochemicals

The main advantage of trading using opposite Jindal Poly and Krebs Biochemicals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jindal Poly position performs unexpectedly, Krebs Biochemicals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krebs Biochemicals will offset losses from the drop in Krebs Biochemicals' long position.
The idea behind Jindal Poly Investment and Krebs Biochemicals and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities